Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The multivariable logistic regression analysis model demonstrated in SD: Standard deviation Table 3 confirmed that seeking the advice of a non: neurologist, receiving a prior misdiagnosis, and the earlier year period of presentation were the three independent predictors of MS diagnostic delay.Criteria of patients according to the initial presentation (motor Vs non-motor).Motor presentation (n = 49)Non-motor presentation (n = 93)Age at onset, mean ± SD30.43 ± 9.50127.28 ± 7.768Sex, no (%) Males17 (34.7)22 (23.7) Females32 (65.3)71 (76.3)First specialty sought no (%) Neurologist36 (73.5)43 (46.2) Ophthalmologist025 (26.9) Orthopedic12 (24.5)12 (12.9) Neurosurgery03 (3.2) General practitioner1 (2.0)7 (7.5) ENT03 (3.2)Previous misdiagnosis no (%) None27 (55.1)35 (37.6) Vascular disorder7 (14.3)11 (11.8) Orthopedic condition14 (28.5)14 (15.0) Space occupying lesion1 (2.0)0 Ophthalmological disorder018 (19.4) ENT condition05 (5.4) Psychiatric condition04 (4.3) Vitamin D deficiency04 (4.3) Trigeminal neuralgia02 (2.2)Time to diagnose MS in months, median26SD, standard deviation.Univariate and multivariate logistic regression analysis for the parameters affecting diagnostic delay in the bivariate analysis (n = 142).Univariate#MultivariatepOR (95% CI)pOR (95% CI)The time of the first presentation < 0.001*0.224 (0.108 to 0.464)0.043*0.255 (0.068 to 0.956) Before 2019 2019 to 2022®Age at onset0.043*0.959 (0.922 to 0.999)0.1310.940 (0.868 to 1.018)1st presentation0.031*2.184 (1.073 to 4.445)0.4931.620 (0.408 to 6.424) Motor presentation ® Non-motor presentation1st specialty sought < 0.001*11.346 (5.132 to 25.086)0.034*4.244 (1.115 to 16.151) Neurologist ® Non-neurologistMisdiagnoses < 0.001*170.0 (36.566 to 790.347) Correct diagnosis® < 0.001*91.697 (17.150 to 490.279) Prior misdiagnosisRelapse rate < 0.001*1.860 (1.431 to 2.418)0.0541.576 (0.992 to 2.502)OR, Odd’s ratio; CI, Confidence interval.*Statistically significant at p ≤ 0.05.#All variables with p < 0.05 was included in the multivariate.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were adults of both sexes diagnosed with RRMS according to the 2017 McDonald’s criteria.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients

Study design awaiting verification · Scientific Reports · 2023

Original publication title

Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients

Eman M. Khedr; Islam El Malky; Hussein B. Hussein; Doaa M. Mahmoud; Ayman Gamea

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The earlier the diagnosis of multiple sclerosis (MS), the sooner disease-modifying treatments can be initiated. However, significant delays still occur in developing countries. We aimed to identify factors leading to delayed diagnosis of MS in Upper Egypt. One hundred forty-two patients with remitting relapsing MS (RRMS) were recruited from 3 MS units in Upper Egypt. Detailed demographic and clinical data were collected. Neurological examination and assessment of the Disability Status Scale (EDSS) were performed. The mean age was 33.52 ± 8.96 years with 72.5% of patients were females.

The mean time from symptom onset to diagnosis was 18.63 ± 27.87 months and the median was 3 months. Seventy-two patients (50.7%) achieved diagnosis within three months after the first presenting symptom (early diagnosis), while seventy patients (49.3%) had more than three months delay in diagnosis (delayed diagnosis). Patients with a delayed diagnosis frequently presented in the period before 2019 and had a significantly higher rate of initial non-motor presentation, initial non-neurological consultations, prior misdiagnoses, and a higher relapse rate.

Another possible factor was delayed MRI acquisition following the initial presentation in sixty-six (46.5%) patients. Multivariable logistic regression analysis demonstrated that earlier presentation, initial non-neurological consultation, and prior misdiagnosis were independent predictors of diagnostic delay. Despite advances in MS management in Egypt, initial non-neurological consultation and previous misdiagnoses are significant factors responsible for delayed diagnosis in Upper Egypt.

Authors’ abstract

The earlier the diagnosis of multiple sclerosis (MS), the sooner disease-modifying treatments can be initiated. However, significant delays still occur in developing countries. We aimed to identify factors leading to delayed diagnosis of MS in Upper Egypt. One hundred forty-two patients with remitting relapsing MS (RRMS) were recruited from 3 MS units in Upper Egypt. Detailed demographic and clinical data were collected. Neurological examination and assessment of the Disability Status Scale (EDSS) were performed. The mean age was 33.52 ± 8.96 years with 72.5% of patients were females.

The mean time from symptom onset to diagnosis was 18.63 ± 27.87 months and the median was 3 months. Seventy-two patients (50.7%) achieved diagnosis within three months after the first presenting symptom (early diagnosis), while seventy patients (49.3%) had more than three months delay in diagnosis (delayed diagnosis). Patients with a delayed diagnosis frequently presented in the period before 2019 and had a significantly higher rate of initial non-motor presentation, initial non-neurological consultations, prior misdiagnoses, and a higher relapse rate.

Another possible factor was delayed MRI acquisition following the initial presentation in sixty-six (46.5%) patients. Multivariable logistic regression analysis demonstrated that earlier presentation, initial non-neurological consultation, and prior misdiagnosis were independent predictors of diagnostic delay. Despite advances in MS management in Egypt, initial non-neurological consultation and previous misdiagnoses are significant factors responsible for delayed diagnosis in Upper Egypt.

Publication and source details

Original title: Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients

Eman M. Khedr; Islam El Malky; Hussein B. Hussein; Doaa M. Mahmoud; Ayman Gamea

Scientific Reports · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Assiut University

Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T20:38:45.572061+00:00

DOI: 10.1038/s41598-023-28864-x · PMC9908930